ARCHIVES

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

This article is from The Cancer Letter archive.

Vol. 16 No. 31 | August 3, 1990

Download PDF Visit The Full Archive

Related Articles

Central Line Safety Intervention Lowers Patient Infection Rate

October 25, 2013

Prognostic Factors Don’t Explain Better Prostate Cancer Survival In Most Asian Men

August 31, 2007

GAO Report On NCI Cancer Control Contracts (Continued)

August 1, 1980

In Brief: Couple Gives $1.1 Mil. To NCI Intramural Research; Kuller Replaces Grufferman At PCI

February 16, 1990

McDonald’s Charity Commits $5 Million To Pediatric Research

May 17, 1991

American Radium Society Abstracts

July 23, 1976